The expansion and contraction of the vessel wall from lipid microspheres under low intensity ultrasound (“stable cavitation”) opens pores to allow more drugs to get into the tumor: "Sonoporation"
All components of our platform are FDA approved or cleared and have been commercially used in humans.
See where our drugs can helpVesselon has a scalable pharmacology platform where we take off-patent, licensed, or novel drugs and create acoustically active conjugates to make them better for new or existing indications.